Promoter hypermethylation in ductal carcinoma in situ of the male breast.
Saved in:
| Title: | Promoter hypermethylation in ductal carcinoma in situ of the male breast. |
|---|---|
| Authors: | Vermeulen MA; Department of Pathology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., van Deurzen CHM; Department of Pathology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.; BOOG Study Center/Dutch Breast Cancer Research Group, Amsterdam, The Netherlands., Doebar SC; Department of Pathology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., de Leng WWJ; Department of Pathology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., Martens JWM; BOOG Study Center/Dutch Breast Cancer Research Group, Amsterdam, The Netherlands.; Department of Medical Oncology and Cancer Genomics Netherlands, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., van Diest PJ; Department of Pathology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., Moelans CB; Department of Pathology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands. |
| Source: | Endocrine-related cancer [Endocr Relat Cancer] 2019 Jun; Vol. 26 (6), pp. 575-584. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: BioScientifica Country of Publication: England NLM ID: 9436481 Publication Model: Print Cited Medium: Internet ISSN: 1479-6821 (Electronic) Linking ISSN: 13510088 NLM ISO Abbreviation: Endocr Relat Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
